An injectable dual-drug-loaded hydrogel for the treatment of bacterial endophthalmitis
Abstract
Bacterial endophthalmitis is a severe ocular infection that frequently leads to severe visual impairment or blindness. Current clinical treatments primarily rely on intravitreal antibiotics to eliminate pathogens; however, these often fail to control the excessive inflammatory response that contributes to irreversible retinal tissue damage. We developed an injectable thermosensitive hydrogel that treats bacterial endophthalmitis via a combined antibacterial and anti-inflammatory strategy. The hydrogel is constructed with a chitosan/β-glycerophosphate/gelatin platform co-loaded with moxifloxacin and a curcumin-cyclodextrin inclusion complex. In vitro injectability, rheological, and drug release studies demonstrated that the hydrogel precursor rapidly formed a gel following intravitreal injection and enabled sustained drug release. Rheological and swelling-degradation investigations confirmed its low mechanical modulus, minimal swelling capacity, and optimal biodegradation profile, thereby avoiding potential ocular discomfort during intraocular application. This system enables rapid release of moxifloxacin to eliminate bacteria, followed by sustained release of curcumin to mitigate inflammation and reduce inflammatory-mediated tissue injury. Both in vitro and in vivo evaluations demonstrated that the hydrogel showed a strong antibacterial efficacy against S. aureus and significant anti-inflammatory activity, leading to preserved retinal structure and improved visual function.…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.